Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 466

1.

BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.

Chang H, Lee H, Yoon SO, Kim H, Kim A, Kim BH.

Hum Pathol. 2012 Jan;43(1):89-95. doi: 10.1016/j.humpath.2011.04.010.

PMID:
21774961
2.

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.

Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107.

PMID:
22181337
3.

Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.

Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A.

World J Surg. 2010 Nov;34(11):2595-603. doi: 10.1007/s00268-010-0729-4.

PMID:
20652698
5.

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.

Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS.

Diagn Mol Pathol. 2008 Jun;17(2):118-25. doi: 10.1097/PDM.0b013e31815d059d.

PMID:
18382358
6.

Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.

Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.

Acta Cytol. 2011;55(6):576-83. doi: 10.1159/000333453.

PMID:
22156469
7.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302.

PMID:
26152656
8.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.

Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021.

PMID:
21568726
9.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
10.

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules.

Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH.

Clin Cancer Res. 2004 Apr 15;10(8):2761-5.

11.

Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study.

Troncone G, Cozzolino I, Fedele M, Malapelle U, Palombini L.

Diagn Cytopathol. 2010 Mar;38(3):172-6. doi: 10.1002/dc.21166.

PMID:
19693938
12.
13.

Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.

Kwak JY, Kim EK, Kim JK, Han JH, Hong SW, Park TS, Choi JR.

Head Neck. 2010 Apr;32(4):490-8. doi: 10.1002/hed.21210.

PMID:
19672964
14.

BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.

Chakraborty A, Narkar A, Mukhopadhyaya R, Kane S, D'Cruz A, Rajan MG.

Endocr Pathol. 2012 Jun;23(2):83-93. doi: 10.1007/s12022-011-9184-5.

PMID:
22105775
15.

BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.

Rossi ED, Martini M, Capodimonti S, Lombardi CP, Pontecorvi A, Vellone VG, Zannoni GF, Larocca LM, Fadda G.

Cancer Cytopathol. 2013 Jun;121(6):291-7. doi: 10.1002/cncy.21258.

16.

[BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].

Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S.

Ann Pathol. 2010 Aug;30(4):252-62. doi: 10.1016/j.annpat.2010.05.011. French.

PMID:
20837233
17.

Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.

Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M.

Cancer Cytopathol. 2014 Jan;122(1):48-58. doi: 10.1002/cncy.21352.

18.

Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.

Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.

Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586.

19.

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.

Cañadas-Garre M, Becerra-Massare P, López de la Torre-Casares M, Villar-del Moral J, Céspedes-Mas S, Vílchez-Joya R, Muros-de Fuentes T, García-Calvente C, Piédrola-Maroto G, López-Nevot MA, Montes-Ramírez R, Llamas-Elvira JM.

Ann Surg. 2012 May;255(5):986-92. doi: 10.1097/SLA.0b013e31824e8d70.

PMID:
22504197
20.

BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.

Ahn D, Park JS, Sohn JH, Kim JH, Park SK, Seo AN, Park JY.

Auris Nasus Larynx. 2012 Apr;39(2):198-203. doi: 10.1016/j.anl.2011.07.011.

PMID:
21862261
Items per page

Supplemental Content

Support Center